Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro

Currently, no rabies virus-specific antiviral drugs are available. Ranpirnase has strong antitumor and antiviral properties associated with its ribonuclease activity. TMR-001, a proprietary bulk drug substance solution of ranpirnase, was evaluated against rabies virus in three cell types: mouse neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Todd G., Jackson, Felix R., Morgan, Clint N., Carson, William C., Martin, Brock E., Gallardo-Romero, Nadia, Ellison, James A., Greenberg, Lauren, Hodge, Thomas, Squiquera, Luis, Sulley, Jamie, Olson, Victoria A., Hutson, Christina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077210/
https://www.ncbi.nlm.nih.gov/pubmed/32033253
http://dx.doi.org/10.3390/v12020177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077210/
https://www.ncbi.nlm.nih.gov/pubmed/32033253
http://dx.doi.org/10.3390/v12020177

Ejemplares similares